Arda Ural is a Partner in EY's Transactions Practice in New York with a focus on Life Sciences and post-acquisition value creation. Prior to EY, he was a Managing Director at Accenture Strategy where he led the LS M&A Practice. Earlier, Arda worked as a VP of Strategic Marketing and a BU Lead at Becton Dickinson. He also served as the SVP Marketing & Sales for a start-up biotechnology company, Eyetech, which went public and was later acquired by OSI/Astellas.
Arda started his career with Pfizer in Istanbul then relocated to New York where he held leadership roles in product commercialization and new product development. He launched Viagra worldwide and led the Celebrex US team. He holds a BSc & MSc from the Bosporus University, an MBA & PhD from Marmara University Istanbul and has completed the Executive Development Program at Harvard.